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Knowledge about the efficacy of the numerous different treatments offered by
physiotherapists is essential for patients, health care professionals (including
physiotherapists) and policymakers. Elsewhere in this volume (Bouter et al 1990) it is
explained why the efficacy of physiotherapeutic interventions should preferably be
studied with randomized clinical trials (RCTs). Meta-analysis refers to a critical
summary of the evidence on the efficacy of an intervention that is based on the
available RCTs on the topic. Meta-analyse-8 usually focus either on the methodological
quality of available trials, or on providing a quantitative summary of the effect
(pooling). Both forms differ from traditional 'impressionistic' reviews by their
explicit and standardized methods. Where traditional review articles tend to rely
heavily on the authority of the reviewer, in meta-analyses the reader is, to a
substantial extent, able to draw his or her own conclusions, which may differ from those
of the author(s).
Meta-analyses seem to have become rather popular recently. The methodology
originally was developed by social scientists (see for example Light & Pillemer 1984) in
the seventies, and has later been adapted for use in the medical field (Greenland 1987,
Sacks et al 1987, Boissel et al 1989). Until now the emphasis has primarily been laid
upon the pooling of RCTs, but growing attention is now being given to a standardized
methodological assessment of the studies involved (Chalmers et al 1981, Goldschmidt
1986, Anonymous 1987, Gerbarg & Horwitz 1988). For the field of physiotherapy, the
latter form, sometimes labelled as 'criterium-based meta-analysis', is probably the most
valuable. The reason for this is that for most physiotherapeutic treatments only a
relatively small number of RCTs will be available, with a large variation in
methodological quality. Consequently, the main topic of this article will be the
methodology of criterium-based meta-analyses.
Firstly, the general aims of meta-analyses will be described. Secondly, potential
sources of bias in the study of literature are presented. Thirdly, some crucial aspects
of the protocol of a meta-analysis are explained. Finally, examples of current and
future use of meta-analysis in the field of physiotherapy will be discussed.
Aims 
The purpose of a meta-analysis can be both clinical and scientific. The clinical
relevance consists of the possibility of getting a more precise estimate of the effect
of an intervention. This is especially important when the available trials have a low
power, which means that each trial has only a small chance of detecting an existing
difference that would be considered to be of clinical relevance. In a meta-analysis the
sensitivity for such a small, but clinically relevant, effect will be elevated
substantially. This can be formalized in a pooled statistical analysis (Yusuf et al
1985, Demets 1987), but the details of this technique fall outside the scope of this
article. Another related advantage of a meta-analysis consists of the improved
possibilities (compared to those in individual trials) of getting an impression of the
effect of the intervention among different groups of patients, and of the influence of
doses, duration of treatment and co-interventions on the efficacy of the treatment at
issue
The scientific relevance of a meta-analysis consists of an explicit summary of the
'state-of-the-art'. In addition to providing an overall judgement with respect to
efficacy, the meta-analysis focuses attention on gaps and methodological weaknesses of
available studies. Consequently, guidelines can be developed for the design of future
RCTs with the aim of answering remaining questions. Meta-analyses are increasingly used
for policy decisions, for instance concerning the registration of a new drug (Furberg &
Morgan 1987) or the coverage of a new treatment by health care insurances (Louis et al
1985).
Sources of bias 
A study of literature is by definition non-experimental and therefore open to the
same forms of bias as other observational studies: selection bias, information bias,
effect modification and confounding (see for example Rothman 1986).
Not all RCTs are carried out, analyzed and published according to the original
planning. Furthermore, 'negative' studies seem to have a substantially smaller chance of
appearing in print, especially when they have a small sample size (Dickersin et al
1987). In other words, small trials that are published will have an elevated chance of
being 'false positives'. This will lead to selection bias on the level of the meta-
analysis by causing an overestimation of the efficacy of the treatment at issue. This
phenomenon is called publication bias for which correction is not easy to perform. The
only real solution to this problem consists of registration of all trials when they are
started, so that later both published and unpublished results can be included in a meta-
analysis (Simes 1987).
Although the performance of RCTs forms a necessary condition for the valid
assessment of the efficacy of an intervention (Bouter et al 1990), this is by no means a
sufficient condition. The (internal) validity of RCTs is often seriously impaired
(Chalmers et al 1981). Furthermore, there are indications that trials of doubtful
methodological quality generally tend to report positive results more often (Louis et al
1985, Ter Riet et al 1990). Inclusion of all RCTs in a meta-analysis, not taking into
account the (internal) validity of the trial, could introduce a substantial amount of
information bias leading to an overestimation of the efficacy of the treatment at issue.
This constitutes a serious problem, especially in a field where the methodological
standards of the RCTs are (still) rather low. An example of this is provided by two
recent meta-analyses of the efficacy of acupuncture in the treatment of chronic pain: a
pooled analysis of 14 of all available (N=51) trials (Patel et al 1989) appeared to lead
to a more optimistic overall judgement than a criterium-based meta-analysis that took
into account the methodological quality of the trials involved (Ter Riet et al 1990).
Although there is nowadays more or less consensus about the criteria for an
(internally) valid RCT (Bouter et al 1990), the application of these criteria and the
weights given to a violation of each of them remains arbitrary to some extent.
Therefore, it is important that standardized and explicit criteria are used by several
expert reviewers who assess the trials independently and are blinded for the results of
the trial, its authors and the journal in which it appeared (Chalmers et al 1987,
Furberg and Morgan 1987, Gerbarg and Horwitz 1988). The reviewers should have a high
level of agreement and are to be recruited both from clinical experts (physiotherapists)
and experts in research methodology (epidemiologists or biostatisticians).
Another important issue in the design of a meta-analysis consists of the
comparability of patients and interventions among the RCTs involved. The question here
is whether the existing differences between the groups of patients and the execution of
the interventions (including co-interventions) will have an influence on the efficacy of
the treatment at issue. Presence of such an influence will lead to effect modification
on the level of the meta-analysis. The solution to this depends on which question the
meta-analysis tries to answer. Often restriction of the meta-analysis to a homogeneous
subgroup of patients or to a specific operationalization of the intervention will be
indicated. But when the purpose is to study the influence of a prognostic factor on the
efficacy of the intervention, the meta-analysis should be divided in clusters
corresponding with this factor (e.g. by presenting the efficacy of ultra sound therapy
separately for acute and for chronic low back pain patients).
Incomparability of effect parameters among the trials involved constitutes another
source of bias which can confound the overall judgement of efficacy (Greenland 1987).
The outcome parameter for which the RCTs are compared should be identical (or at least
very similar) in all trials involved. Often some form of standardization, for example
the percentage of pain reduction, will be necessary to enable comparison.
Protocol for a meta-analysis 
Like every empirical study, a meta-analysis needs an explicit research protocol that
is formulated before the review of the literature is executed. This protocol will state
the central question the meta-analysis tries to answer, and contains details about
inclusion and exclusion criteria for trials and the items and weights of the
methodological assessment. Furthermore, the protocol will provide information on the way
standardization and blinding of the procedure will be guaranteed. Because of differences
in subjects and aims, every meta-analysis will need its own protocol (Louis et al 1985,
Sacks et al 1987, Furberg and Morgan 1987). Therefore, this section can only present
some general guidelines.
The inclusion and exclusion criteria deal primarily with the patients, intervention:;
and effect parameters that are eligible. In addition to this, they can contain, for
instance, a minimal duration of follow-up, or mention a period in which the study has to
be executed or published. Next, the method of identification of eligible trials has to
be stated explicitly. Usually computerized data bases (e.g. Index Medicus, Excerpta
Medica and Current Contents) are used as a starting point. This will by no means
identify all eligible trials, because the key words of these systems are not very
appropriate for physiotherapeutic purposes and not all journals relevant to
physiotherapists are abstracted. Therefore, additional sources should be used, like
textbooks, earlier reviews, lists of references and\correspondence with experts in the
field (Sacks et al 1987). Especially if one wants to minimize publication bias by
including unpublished data as well, sending a questionnaire to all authors of relevant
publications already identified can be very helpful.
An important part of the protocol deals with the methodological assessment of the
trials. The reviewers of the methodological quality of the trials ought to be selected
and they will have to agree upon the items they will focus on. These items will partly
deal with methodological issues that are central in all RCTs (e.g. method of
randomization, loss to follow-up or use of a placebo treatment; see for instance
Fletcher et al 1988). Next to these, it is usual to add a number of items (e.g. dealing
with the choice of the effect parameters, the-execution of the interventions or relevant
variables for the assessment of prognostic comparability) which are more specific for
the subject at issue. When a certain weight is allocated to the items, for each trial an
overall score for methodological quality can be calculated (Chalmers et al 1981, Ter
Riet et al 1990).
The protocol of the meta-analysis should state clearly whether and for what aspects
(results, authors or journal) the methodological assessment will be blinded. Of course,
blinding has to be realized by a person not involved in reviewing the trials.
Unfortunately, reading the methods section only will usually not be sufficient, because
relevant methodological details may be found in other sections of the article as well.
After an initial assessment of the trials by the reviewers, it may be necessary to
operationalize some items further before the overall methodological score can be
calculated. The publication in which the results of the meta-analysis are presented
should preferably specify the level of agreement between the reviewers and enable the
reader to generate his or her own judgement by applying other weights to the
methodological items.
Discussion
The principles of reviewing the literature on the efficacy of a physiotherapeutic
treatment that are mentioned in this article are relatively new and by no means fully
developed. Criterium-based meta-analyses as advocated above are still not very common
(Dickersin et al 1987, Gerbarg & Horwitz 1988). Most meta-analyses published in the
medical field focus on generating a quantitative summary (pooling) of all available
evidence, largely ignoring differences in methodological quality of the trials at issue
(Sacks et al 1987). We think that for the situation in the physiotherapeutic literature
the latter would be an example of bad practice. The reason for this is that RCTs on the
efficacy of a physiotherapeutic treatment tend to vary substantially with respect to
methodological quality. Moreover, for a given question of efficacy in the
physiotherapeutic realm usually only a limited number of RCTs (0-20) are available, so
there is no need for pooling the results.
Recently, a number of criterium-based meta-analyses were performed at our
department. One of them deals with the efficacy of acupuncture in the treatment of
chronic pain and is presented elsewhere in this volume (Ter Riet et al 1990). Currently
we are executing a large literature study on the efficacy of physiotherapeutic
interventions, including treatment modalities like electro therapy, ultra sound,
traction, laser therapy and manipulative therapy, all for several indications. In this
project the idea of criterium-based meta-analyses will be tested critically and
developed further with special attention to feasibility and informativity.
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